Turn On, Tune In But Don’t Drop Out: The Pending Boom In Psychedelic Medicines
While local investors are unfamiliar with psychedelic therapy, this is likely to change given the burgeoning interest in North America, where no fewer than 20 companies are actively involved in the field.
Read More